|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA, Torre LA and Jemal A: Global cancer statistics 2018:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 68:394–424.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Katoh M and Katoh M: Identification and
characterization of ARHGAP24 and ARHGAP25 genes in silico. Int J
Mol Med. 14:333–338. 2004.PubMed/NCBI
|
|
3
|
Lindner SE, Egelston CA, Huard SM, Lee PP
and Wang LD: Arhgap25 deficiency leads to decreased numbers of
peripheral blood B cells and defective germinal center reactions.
Immunohorizons. 4:274–281. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Csépányi-Kömi R, Sirokmány G, Geiszt M and
Ligeti E: ARHGAP25, a novel Rac GTPase-activating protein,
regulates phagocytosis in human neutrophilic granulocytes. Blood.
119:573–582. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Csépányi-Kömi R, Wisniewski É, Bartos B,
Lévai P, Németh T, Balázs B, Kurz AR, Bierschenk S, Sperandio M and
Ligeti E: Rac GTPase activating protein ARHGAP25 regulates
leukocyte transendothelial migration in mice. J Immunol.
197:2807–2815. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tao L, Zhu Y, Gu Y, Zheng J and Yang J:
ARHGAP25: A negative regulator of colorectal cancer (CRC)
metastasis via the Wnt/β-catenin pathway. Eur J Pharmacol.
858(172476)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jensen EC: Quantitative analysis of
histological staining and fluorescence using ImageJ. Anat Rec
(Hoboken). 296:378–381. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Varghese F, Bukhari AB, Malhotra R and De
A: IHC profiler: An open source plugin for the quantitative
evaluation and automated scoring of immunohistochemistry images of
human tissue samples. PLoS One. 9(e96801)2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Choi J, Dekkers OM and le Cessie S: A
comparison of different methods to handle missing data in the
context of propensity score analysis. Eur J Epidemiol. 34:23–36.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pedersen AB, Mikkelsen EM, Cronin-Fenton
D, Kristensen NR, Pham TM, Pedersen L and Petersen I: Missing data
and multiple imputation in clinical epidemiological research. Clin
Epidemiol. 9:157–165. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
White IR and Carlin JB: Bias and
efficiency of multiple imputation compared with complete-case
analysis for missing covariate values. Stat Med. 29:2920–2931.
2010.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Wong CK, Lam CL, Poon JT, McGhee SM, Law
WL, Kwong DL, Tsang J and Chan P: Direct medical costs of care for
Chinese patients with colorectal neoplasia: A health care service
provider perspective. J Eval Clin Pract. 18:1203–1210.
2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vega FM and Ridley AJ: Rho GTPases in
cancer cell biology. FEBS Lett. 582:2093–2101. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bernards A: GAPs galore! A survey of
putative Ras superfamily GTPase activating proteins in man and
Drosophila. Biochim Biophys Acta. 1603:47–82. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tcherkezian J and Lamarche-Vane N: Current
knowledge of the large RhoGAP family of proteins. Biol Cell.
99:67–86. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Thuault S, Comunale F, Hasna J, Fortier M,
Planchon D, Elarouci N, De Reynies A, Bodin S, Blangy A and
Gauthier-Rouvière C: The RhoE/ROCK/ARHGAP25 signaling pathway
controls cell invasion by inhibition of Rac activity. Mol Biol Cell
Cell. 27:2653–2661. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xu K, Liu B and Ma Y: The tumor
suppressive roles of ARHGAP25 in lung cancer cells. Onco Targets
Ther. 12:6699–6710. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Derwinger K, Carlsson G and Gustavsson B:
A study of lymph node ratio as a prognostic marker in colon cancer.
Eur J Surg Oncol. 34:771–775. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mehrkhani F, Nasiri S, Donboli K, Meysamie
A and Hedayat A: Prognostic factors in survival of colorectal
cancer patients after surgery. Colorectal Dis. 11:157–161.
2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nitsche U, Friess H, Agha A, Angele M,
Eckel R, Heitland W, Jauch KW, Krenz D, Nüssler NC, Rau HG, et al:
Prognosis of mucinous and signet-ring cell colorectal cancer in a
population-based cohort. J Cancer Res Clin Oncol. 142:2357–2366.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Serra-Rexach JA, Jimenez AB,
Garcia-Alhambra MA, Pla R, Vidán M, Rodriguez P, Ortiz J,
García-Alfonso P and Martín M: Differences in the therapeutic
approach to colorectal cancer in young and elderly patients.
Oncologist. 17:1277–1285. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Majek O, Gondos A, Jansen L, Emrich K,
Holleczek B, Katalinic A, Nennecke A, Eberle A and Brenner H: GEKID
Cancer Survival Working Group. Sex differences in colorectal cancer
survival: Population-based analysis of 164,996 colorectal cancer
patients in Germany. PLoS One. 8(e68077)2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Compton C, Fenoglio-Preiser CM, Pettigrew
N and Fielding LP: American joint committee on cancer prognostic
factors consensus conference: Colorectal working group. Cancer.
88:1739–1757. 2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Newland RC, Dent OF, Lyttle MN, Chapuis PH
and Bokey EL: Pathologic determinants of survival associated with
colorectal cancer with lymph node metastases. A multivariate
analysis of 579 patients. Cancer. 73:2076–2082. 1994.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shepherd NA, Baxter KJ and Love SB: The
prognostic importance of peritoneal involvement in colonic cancer:
A prospective evaluation. Gastroenterology. 112:1096–1102.
1997.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Park YJ, Park KJ, Park JG, Lee KU, Choe KJ
and Kim JP: Prognostic factors in 2230 Korean colorectal cancer
patients: Analysis of consecutively operated cases. World J Surg.
23:721–726. 1999.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Vasile L, Olaru A, Munteanu M, Pleşea IE,
Surlin V and Tudoraşcu C: Prognosis of colorectal cancer: Clinical,
pathological and therapeutic correlation. Rom J Morphol Embryol.
53:383–391. 2012.PubMed/NCBI
|
|
29
|
Missiaglia E, Jacobs B, D'Ario G, Di Narzo
AF, Soneson C, Budinska E, Popovici V, Vecchione L, Gerster S, Yan
P, et al: Distal and proximal colon cancers differ in terms of
molecular, pathological, and clinical features. Ann Oncol.
25:1995–2001. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tejpar S, Stintzing S, Ciardiello F,
Tabernero J, Van Cutsem E, Beier F, Esser R, Lenz HJ and Heinemann
V: Prognostic and predictive relevance of primary tumor location in
patients With RAS wild-type metastatic colorectal cancer:
Retrospective analyses of the CRYSTAL and FIRE-3 trials. JAMA
Oncol. 3:194–201. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Derwinger K, Kodeda K, Bexe-Lindskog E and
Taflin H: Tumour differentiation grade is associated with TNM
staging and the risk of node metastasis in colorectal cancer. Acta
Oncol. 49:57–62. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kanazawa T, Watanabe T, Kazama S, Tada T,
Koketsu S and Nagawa H: Poorly differentiated adenocarcinoma and
mucinous carcinoma of the colon and rectum show higher rates of
loss of heterozygosity and loss of E-cadherin expression due to
methylation of promoter region. Int J Cancer. 102:225–229.
2002.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mirkin KA, Kulaylat AS, Hollenbeak CS and
Messaris E: Prognostic significance of tumor deposits in stage III
colon cancer. Ann Surg Oncol. 25:3179–3184. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Nagayoshi K, Ueki T, Nishioka Y, Manabe T,
Mizuuchi Y, Hirahashi M, Oda Y and Tanaka M: Tumor deposit is a
poor prognostic indicator for patients who have stage II and III
colorectal cancer with fewer than 4 lymph node metastases but not
for those with 4 or more. Dis Colon Rectum. 57:467–474.
2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Liu X, Xiu LJ, Jiao JP, Zhao J, Zhao Y, Lu
Y, Shi J, Li YJ, Ye M, Gu YF, et al: Traditional Chinese medicine
integrated with chemotherapy for stage IV non-surgical gastric
cancer: A retrospective clinical analysis. J Integr Med.
15:469–475. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yang X, Hao J, Zhu CH, Niu YY, Ding XL,
Liu C and Wu XZ: Survival benefits of western and traditional
Chinese medicine treatment for patients with pancreatic cancer.
Medicine (Baltimore). 94(e1008)2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tsouma A, Aggeli C, Lembessis P, Zografos
GN, Korkolis DP, Pectasides D, Skondra M, Pissimissis N, Tzonou A
and Koutsilieris M: Multiplex RT-PCR-based detections of CEA, CK20
and EGFR in colorectal cancer patients. World J Gastroenterol.
16:5965–5974. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Diaconescu A, Alexandrescu S, Ionel Z,
Zlate C, Grigorie R, Brasoveanu V, Hrehoret D, Ciurea S, Botea F,
Tomescu D, et al: Resection of concomitant hepatic and extrahepatic
metastases from colorectal cancer-a worthwhile operation? Chirurgia
(Bucur). 112:673–682. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Luo M, Chen SL, Chen J, Yan H, Qiu Z, Chen
G, Lu L and Zhang F: Resection vs ablation for lesions
characterized as resectable-ablative within the colorectal liver
oligometastases criteria: A propensity score matching from
retrospective study. PeerJ. 8(e8398)2020.PubMed/NCBI View Article : Google Scholar
|
